Aurobindo Pharma Limited announced that Mr. N. Govindarajan has tendered his resignation as Director on the Board of the Company due to personal reasons. His resignation was considered and accepted by the Board of Directors in its meeting held on October 1, 2021. Mr. N. Govindarajan will be relieved from the services of the Company effective from the close of business on December 31,2021. The Board has also taken note of the appointment of Mr. S. Damodharan as Chief Operating Officer for the API vertical. Mr. S. Damodharan is a Chemical Engineer with 32 years of experience in pharmaceutical sectors and worked with major reputed pharmaceutical companies in the API business. He is responsible for API plant operations and other related functions.